Coherent's Q1 Blowout: Execution Confirmed, Valuation Risk Intensifies

What happened

Coherent reported Q1 FY27 revenue of $2.37B, up 50% Y/Y (56% pro forma), with non-GAAP gross margin of 40.6% and non-GAAP EPS of $2.09, blowing past the prior quarter's guidance and the roadmap set in the May 2026 report. The results validate the core thesis that indium phosphide capacity expansion and datacenter demand are converting into profitable shipments, as revenue growth accelerated and margin expanded sequentially. However, the stock was already priced for significant execution at $333 in July 2026, trading at 145x earnings and 49x EV/EBITDA, and these blowout numbers likely push valuation even higher unless the multiple compresses. The report's key risk factors remain: inventory buildup, customer concentration, and the need to sustain datacenter growth above 25% Y/Y, none of which are directly addressed in this earnings release. While the quarter is undeniably strong, investors must ask whether even this level of execution justifies the premium, especially as the company approaches the upper end of the report's trim threshold.

Implication

The Q1 FY27 beat demonstrates that Coherent's 6-inch InP ramp and AI-driven datacenter demand are delivering faster than expected, supporting the bull case's operating outcome of revenue above $2B and gross margin above 40%. However, the stock's valuation was already stretched with a P/E of 145 and EV/EBITDA of 49, and these results may push the price further into the report's 'trim above $390' zone, reducing the margin of safety. Investors should monitor whether the company can convert this growth into cash flow; the previous nine months showed only $10M operating cash flow due to inventory build, and this quarter's release does not provide balance sheet details. The re-assessment window suggests waiting for confirmation that inventory growth slows relative to datacenter revenue and that gross margin sustains above 39.6% for two consecutive quarters, which now appears likely but not yet certain. For new positions, the attractive entry remains around $285, and chasing the stock after a blowout quarter risks overpaying for already-high expectations.

Thesis delta

The thesis is unchanged but strengthened on execution evidence: Q1 FY27 revenue and margin exceed prior guidance, confirming that the InP manufacturing advantage is converting into shipments. However, the valuation concern is now more acute because the stock likely trades even further above intrinsic value, and the main risk has shifted from execution to paying too high a price for that execution. No change in rating; WAIT remains appropriate until the stock offers a better entry point.